Suppr超能文献

并发疾病管理指南。系统评价。

Concurrent Disorder Management Guidelines. Systematic Review.

作者信息

Hakobyan Syune, Vazirian Sara, Lee-Cheong Stephen, Krausz Michael, Honer William G, Schutz Christian G

机构信息

Department of Psychiatry, The University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Department of Public Health, King's College London, London WC2R 2LS, UK.

出版信息

J Clin Med. 2020 Jul 28;9(8):2406. doi: 10.3390/jcm9082406.

Abstract

Concurrent disorder refers to a diverse set of combinations of substance use disorders and mental disorders simultaneously in need of treatment. Concurrent disorders are underdiagnosed, undertreated, and more complex to manage, practicing the best recommendations can support better outcomes. The purpose of this work is to systematically assess the quality of the current concurrent disorders' clinical recommendation management guidelines. Literature searches were performed by two independent authors in electronic databases, web, and gray literature. The inclusion criteria were English language clinical management guidelines for adult concurrent disorders between 2000 and 2020. The initial search resulted in 8841 hits. A total of 24 guidelines were identified and assessed with the standardized guidelines assessment tool: AGREE II (Appraisal of Guidelines for Research and Evaluation). Most guidelines had acceptable standards, however, only the NICE guidelines had all detailed information on all AGREE II Domains. Guidelines generally supported combinations of treatments for individual disorders with a very small evidence base for concurrent disorders, and they provided little recommendation for further structuring of the field, such as level of complexity or staging, or evaluating different models of treatment integration.

摘要

共病指的是物质使用障碍和精神障碍同时存在且需要治疗的多种不同组合情况。共病的诊断不足、治疗不足且管理起来更为复杂,遵循最佳建议有助于取得更好的治疗效果。这项工作的目的是系统评估当前共病临床推荐管理指南的质量。两名独立作者在电子数据库、网络和灰色文献中进行了文献检索。纳入标准为2000年至2020年间针对成人共病的英文临床管理指南。初步检索得到8841条结果。共识别出24项指南,并使用标准化指南评估工具AGREE II(研究与评估指南评估)进行评估。大多数指南具有可接受的标准,然而,只有英国国家卫生与临床优化研究所(NICE)的指南在AGREE II的所有领域都有详细信息。指南通常支持针对个体障碍的治疗组合,但对于共病的证据基础非常少,并且它们对于该领域的进一步结构化,例如复杂性水平或分期,或评估不同的治疗整合模式,几乎没有提供建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c03f/7463987/f564d33a6535/jcm-09-02406-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验